Abstract
The study was undertaken to find out the effects of over supplementation of dietary calcium and vitamin D3 on the mineralization of growing skeleton, taking rabbit as an animal model; further to study the effects of Nandrolone deconoate and TGF-β1 on the mineralization of osteopenic bones. Twenty four New Zealand White rabbits of either sex, 60 day old, were randomly divided in 4 equal groups, A, B, C and D. The animals of groups B, C and D were administered with oral supplementation of calcium (2000 mg/kg of standard rabbit feed) and vit-D3 (1000 IU/kg of standard feed) for 60 days. The animals of group A were given standard ration without any supplementation. After 60 days, the Ca-vit.D3 supplementation was discontinued; and the animals of group C were administered with TGF-β1 (10 ng, i.m.) once in every three days and animals of group D were given Nandrolone deconoate (10 mg, i.m.) once every week for 30 days, whereas in animals of group B, no treatment was given. All the animals were evaluated based on different observations like body weight, radiographic observations, circulating biochemical and hormone profile (plasma Ca, IP, AP, OC and iPTH) every 15 days up to 60 days after initiation of treatment. The results indicated that the body weight of rabbits in different groups increased gradually and steadily at different intervals till the end of observation period, however, the increase was non-significantly more in group D. The CI in group A increased gradually at different intervals; whereas in groups B, C and D, there was no appreciable increase in the CI during the period of Ca-vit.D3 supplementation, suggesting development of osteopenia. Treatment with TGF-β1 did not increase the CI significantly, whereas Nandrolone treatment resulted in significant increase in the CI on days 45 and 60. The plasma Ca levels showed slight but gradual increase from day 0 to 60 in almost all groups. Subsequently also, there was no marked change at different intervals in groups A and B; however, significant reduction in plasma Ca was noticed in group C on 15th day and in group D on 60th day after initiation of treatment. Plasma IP levels in groups B and C showed a decreasing trend up to day 60. After discontinuation of Ca-vit.D3 supplementation, in group B, it further decreased to remain significantly lower on 15th day, and in groups C and D, it increased significantly on 60th post-treatment day. There was no significant change in the AP activity during the entire period of study in group A; whereas significant reduction in AP activity was measured on 30th and 60th days of treatment in groups B and C, and on 15th day of treatment in group D. Plasma iPTH values did not show any significant change at any interval during the first 60 days in all groups. On 30th and 60th days of treatment, the mean iPTH level remained significantly lesser in group B. In all groups treated with over supplementation of Ca and vit.D3, there was a non-significant increase in the plasma OC levels up to day 60; however, there was no significant difference between the groups. It can be concluded that additional supplementation of Ca and vit.D3 results in osteopenia in growing rabbits. Administration of Nandrolone helps to increase the mineral density in osteopenic bones, whereas TGF-β1 does not seem to have positive effect on the skeletal mineralization.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
analysis of variance
- TGF-β1:
-
transforming growth factor-β1
- iPTH:
-
intact parathyroid hormone
- CI:
-
cortical index
- Ca:
-
calcium
- IP:
-
inorganic phosphorus
- AP:
-
alkaline phosphatase
References
Bae, C.S., and Bae, C.S., 1999. Therapeutic effects of 1-alpha, 25 dihydroxy cholecalciferol on osteoporotic fracture in a rat model. Korean Journal of Veterinary Research, 39, 974–985
Bennett, D., 1976. Nutrition and bone disease in the dog and cat. Veterinary Record, 98, 313–320
Bouillon, R., Caopmans, W., De Groole, D.E.H., Radous, D. and Eliard, P.H., 1990. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region specific antibodies. Clinical Chemistry, 36, 271–276
Braden, T.D., 1993. Histophysiology of the growth plate and growth plate injuries. In: M.J. Bojrab (Ed), Disease Mechanisms in Small Animal Surgery, 2nd edn. (Lea and Febiger, Philadelphia), 1027–1041
Brown, J.P. and Delmas, P.D., 1984. Serum BGP: A specific marker for bone formation in post-menopausal osteoporosis. The Lancet, 1091–1093 doi:10.1016/S0140–6736(84)92506–6
Campbell, J.R. and Griffiths, I.R., 1984. Bone and muscles. In: E.A. Chandler, J.B. Sutton and D.J. Thompson (Eds), Canine Medicine and Therapeutics, 2nd edn, (Blackwell, Oxford), 138–166
Dammrich, K., 1991. Relation between nutrition and bone growth in large and giant dogs. Journal of Nutrition, 121, S114-S121
Deroisy, R., Collette, J., Albert, J., Juspin, I. and Reginster, J.Y., 2002. Administration of supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25 (OH) vitamin D circulatory level. Aging Clinical and Experimental Research, 14, 13–17
Egerman, M., Goldhahn, J. and Schneider, E., 2005. Animal models for fracture treatment in osteoporosis. Osteoporosis International, 16, S129-S138 doi:10.1007/s00198–005–1859–7
Fujimoto, R., Tanizawa, T., Nishida, S., Yamamoto, N., Endo, N. and Takahashi, I., 1999. Local effects of transforming growth factor-BETA.1 on rat calvaria: Changes depending on the injection site. Journal of Bone Mineral Metabolism, 17, 11–17 doi:10.1007/s007740050057
Gomorri, G., 1942. A modification of calorimetric phosphorus determination. Journal of Laboratory Clinical Medicine, 21, 955–958
Hassani, S., Braunstein, G.D., Seibel, M.J., Brickman, A.S., Geola, F., Pekary, A.E., Hershman, J.M., 2001. Alendronate therapy of primary hyperparathyroidism. Endocrinologist, 11, 459–464
Hazewinkel, H.A., 1987. Influences of different calcium intake on calcitropic hormones and skeletal development in young growing dogs. Frontiers of Hormone Research, 17, 221–232
Hazewinkel, H.A., 1991. Dietary influences on calcium homeostasis and the skeleton. In: Proceedings of the purina International Nutrition Symposium, Eastern States Veterinary Conference, (Orlando, Florida), 51–59
Hedhammar, A., Wu, F.M., Krook, L., Schryver, H.F., De Lahunta, A., Wahlen, J.P., Kallfelz, F.A., Nunez, E.A., Hintz, H.F., Sheffy, B.E. and Ryan, G.D., 1974. Overnutrition and skeletal disease. An experimental study in growing Great Dane dogs. Cornell Veterinarian, 64 S-5, 1–60
Jerome, C.P., Power, R.A., Obasanjo, I.O., Register, T.C., Guidry, M., Carlson, C.S. and Weaver, D.S., 1997. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus mokeys. Bone, 20, 335–364 doi:10.1016/S8756–3282(97)00008–2
Johnson, T.E., Moris, D.C. and Anderson, H.C., 1989. Matrix vesicle and calcification of rachitic rat osteoid. Journal of Experimental Pathology, 4, 123–132
Jubb, K.V.F., Kennedy, P.C. and Palmer, N., 1995. Pathology of Domestic Animals, 4th edn, (Academic Press, New York), 34–50
Kardinaal, A.F., Hoorneman, G., Vaananen, K., Chartes, P., Ando, S., Maggiolini, M., Charzewska, J., Rotily, M., Deloraine, A., Heikkinen, J., Juvin, R. and Schaafsma, G., 2000. Determinants of bone mass and bone geometry in adolescent, young and adult women. Calcified Tissue International, 66, 81–89 doi:10.1007/PL00005834
Kind, P.R.N. and King, E.J., 1954. Journal of Clinical Pathology, 7, 322 (cited by Span diagnostic Limited, Surat, India) doi:10.1136/jcp.7.4.322
Lamb, C.R., 1990. The double cortical line: A sign of osteopenia. Journal of Small Animal Practice, 31, 189–192 doi:10.1111/j.1748–5827.1990.tb00768.x
Lavelle, R.B., 1989. The effect of the overfeeding of a balanced complete commercial diet to a group of growing great danes. In: I.H. Burger and J.P.W. Rivers (Eds), Nutrition of the Dog and Cat, (Camgridge University Press), 303–315
Li, X., Takahashi, M., Kushida, K., Shimizu, S., Hoshino, H., Suzuki, M. and Inoue, T., 2000. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia. Journal of Bone Mineral Metabolism, 18, 258–263 doi:10.1007/PL00010639
Loveridge, N., Farquharson, C., Hesketh, J.E., Jackowlew, S.B., Whitehead, C.C. and Thorp, B.H., 1993. The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-b1 and proto-oncogene C-myc. Journal of Cell Science, 105, 949–956
Morike, M., Windsheimer, E., Brenner, R., Nerlich, A., Bushart, G., Teller, W., Vetter, U., 1993. Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta. Journal of Orthopaedic Research, 564–572 doi:10.1002/jor.1100110411
Nuti, R., Righi, G.A., Turchetti, V. and Vattimo, A., 1984. Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium. Minerva Medica, 75, 109–113.
Olsson, S.E., 1993. Pathophysiology, morphology, and clinical signs of osteochondrosis in dog. In: M.J. Bojrab (Ed), Disease Mechanisms in Small Animal Surgery, 2nd edn, (Lea and Febiger, Philadelphia), 776–796
Parti, M., Aithal, H.P., Amarpal, Kinjavdekar, P., Pawde, A.M., Singh, G.R., Goswami, T.K. and Setia, H.C., 2008. Evaluation of certain antiresorptive drugs in growing dogs affected with osteopenic bone diseases (rickets, NSH). Indian Journal of Animal Sciences (in press).
Roberts, A.B. and Sporn, M.B., 1993. Physiological actions and clinical application of transforming growth factor-beta (TGF-beta). Growth Factor, 8, 1–9
Rosol, J.T. and Capen, C.C., 1997. Calcium regulating hormones and diseases of abnormal mineral metabolism. In: J.J. Kaneko, J.W. Harvey, and L.M. Bruss (Eds), Clinical Bio-chemistry of Domestic Animals, 5th edn, (Academic Press, San Diego), 644
Rossow, N., Ehlke, S. and Jacobi, U., 1977. Therapy and prophylaxis of generalized osteopathy in ewe lambs. Monatshefte fur Veterinarmedizin, 32, 543–547
Rubin, M.R., Lee, K.H., McMahon, D.J. and Silverberg, S.J., 2003. Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 88, 1174–1178 doi:10.1210/jc.2002–020667
Schoenmakers, I., Hazewinkel, H.A.W., Voorhout, G., Carlson, C.S. and Richardson, D., 2000. Effect of diets with different calcium and phosphorus contents on the skeletal development and blood chemistry of growing Great Danes. Veterinary Record, 147, 652–660
Schot, L.P., Schuurs, A.H. and Kloosterboer, H.J., 1993. The action of anabolic steroids on bone in experimental animals. Wien Med Wochenschr, 143, 385–387
Shiraki, M., Kushida, K., Fukunaga, M., Kishimoto, H., Kaneda, K., Minaguchi, H., Inoue, T., Tomita, A., Nagata, Y., Nakashima, M. and Orimo, H., 1998. A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group. Endocrinology Journal, 45, 191–201
Slater, M.R., Scarlett, J.M., Donoghue, S., Kaderly, R.E., Bonnett, B.N., Cockshutt, J. and Erb, H.N., 1992. Diet and exercise as potential risk factors for osteochondritis dissecans in dogs. American Journal of Veterinary Research, 53, 2119–2124
Spencer, G.R., 1979. Pregnancy and lactational osteoporosis: Animal model: porcine lactational osteoporosis. American Journal of Pathology, 95, 277–280
Sporn, M.B. and Roberts, A.B., 1990. TGF-beta: Problems and prospects. Cell Regulat, 1, 875–882
Webster, W.W. Jr., 1962. A simple microspectrophotometric method for the determination of serum/plasma calcium. American Journal of Clinical Pathology, 31, 330–333
Young, J.M., 1967. Origins of serum alkaline phosphatase. Journal of Clinical Pathology, 20, 647–653 doi:10.1136/jcp.20.4.647
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aithal, H.P., Kinjavdekar, P., Amarpal et al. Effects of Nandrolone and TGF-β1 in growing rabbits with osteopenia induced by over-supplementation of calcium and vitamin D3. Vet Res Commun 33, 331–343 (2009). https://doi.org/10.1007/s11259-008-9181-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-008-9181-4